Kamu erişimi zorunlu olan makaleler - Roger A BarkerDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 32
İncele
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
GW Duncan, TK Khoo, AJ Yarnall, JT O'Brien, SY Coleman, DJ Brooks, ...
Movement disorders 29 (2), 195-202, 2014
Zorunlu olanlar: UK Medical Research Council, Parkinson's UK
İncele
Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
A Goris, CH Williams‐Gray, GR Clark, T Foltynie, SJG Lewis, J Brown, ...
Annals of neurology 62 (2), 145-153, 2007
Zorunlu olanlar: Research Foundation (Flanders)
İncele
The clinical heterogeneity of Parkinson's disease and its therapeutic implications
JC Greenland, CH Williams‐Gray, RA Barker
European Journal of Neuroscience 49 (3), 328-338, 2019
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
İncele
Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease
LL Kilarski, JP Pearson, V Newsway, E Majounie, MDW Knipe, ...
Movement Disorders 27 (12), 1522-1529, 2012
Zorunlu olanlar: Parkinson's UK
İncele
Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
JG de Yebenes, B Landwehrmeyer, F Squitieri, R Reilmann, A Rosser, ...
The Lancet Neurology 10 (12), 1049-1057, 2011
Zorunlu olanlar: Government of Spain
İncele
Gray and white matter imaging: A biomarker for cognitive impairment in early P arkinson's disease?
GW Duncan, MJ Firbank, AJ Yarnall, TK Khoo, DJ Brooks, RA Barker, ...
Movement Disorders 31 (1), 103-110, 2016
Zorunlu olanlar: National Institute for Health Research, UK, Parkinson's UK
İncele
Time course of dopamine neuron loss and glial response in the 6‐OHDA striatal mouse model of P arkinson's disease
SRW Stott, RA Barker
European Journal of Neuroscience 39 (6), 1042-1056, 2014
Zorunlu olanlar: Parkinson's UK
İncele
Huntington’s disease: Diagnosis and management
TB Stoker, SL Mason, JC Greenland, ST Holden, H Santini, RA Barker
Practical neurology 22 (1), 32-41, 2022
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK
İncele
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
R Reilmann, A McGarry, ID Grachev, JM Savola, B Borowsky, E Eyal, ...
The Lancet Neurology 18 (2), 165-176, 2019
Zorunlu olanlar: US National Institutes of Health, German Research Foundation, UK Medical …
İncele
Determinants of delayed diagnosis in Parkinson’s disease
DP Breen, JR Evans, K Farrell, C Brayne, RA Barker
Journal of Neurology 260, 1978-1981, 2013
Zorunlu olanlar: Parkinson's UK
İncele
The spectrum of clinical features seen with alpha synuclein pathology
RA Barker, CH Williams‐Gray
Neuropathology and applied neurobiology 42 (1), 6-19, 2016
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
İncele
Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome
SE Winder‐Rhodes, P Garcia‐Reitböck, M Ban, JR Evans, TS Jacques, ...
Movement disorders 27 (2), 312-315, 2012
Zorunlu olanlar: Parkinson's UK
İncele
Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain
RA Barker, I de Beaufort
Progress in neurobiology 110, 63-73, 2013
Zorunlu olanlar: UK Medical Research Council, Parkinson's UK, Wellcome Trust
İncele
Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease
P McColgan, JR Evans, DP Breen, SL Mason, RA Barker, ...
Movement Disorders 27 (9), 1173-1177, 2012
Zorunlu olanlar: Parkinson's UK
İncele
Excessive daytime sleepiness and its risk factors in incident Parkinson's disease
DP Breen, CH Williams-Gray, SL Mason, T Foltynie, RA Barker
Journal of Neurology, Neurosurgery & Psychiatry 84 (2), 233-234, 2013
Zorunlu olanlar: Parkinson's UK
İncele
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations
WR Galpern, J Corrigan-Curay, AE Lang, J Kahn, D Tagle, RA Barker, ...
The Lancet Neurology 11 (7), 643-650, 2012
Zorunlu olanlar: US National Institutes of Health, Canadian Institutes of Health Research
İncele
Recent advances in the development of stem‐cell‐derived dopaminergic neuronal transplant therapies for Parkinson's disease
PA Barbuti, RA Barker, P Brundin, S Przedborski, SM Papa, LV Kalia, ...
Movement Disorders 36 (8), 1772-1780, 2021
Zorunlu olanlar: US National Institutes of Health, Canadian Institutes of Health Research …
İncele
Human fetal neural precursor cells can up-regulate MHC class I and class II expression and elicit CD4 and CD8 T cell proliferation
RL Goya, R Busch, R Mathur, AJ Coles, RA Barker
Neurobiology of Disease 41 (2), 407-414, 2011
Zorunlu olanlar: Versus Arthritis, UK
İncele
Stem cells and the treatment of Parkinson's disease
F Ali, SRW Stott, RA Barker
Experimental neurology 260, 3-11, 2014
Zorunlu olanlar: National Institute for Health Research, UK, Wellcome Trust
İncele
Predictors of Parkinson's disease dementia: towards targeted therapies for a heterogeneous disease
SF Moore, RA Barker
Parkinsonism & related disorders 20, S104-S107, 2014
Zorunlu olanlar: Parkinson's UK, Wellcome Trust
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir